source
- China biotech RiboX reports first human data for circular RNA therapiesChina biotech company RiboX has disclosed its initial human data on circular RNA therapeutics, marking the first clinical readout for this emerging platform. The study represents a milestone for t…
- Isomorphic Labs' soaring valuation sparks debate over AI’s impact on drug development and healthcare costsIsomorphic Labs, a biotech spin‑out that applies generative AI to design new medicines, recently secured a multi‑billion‑dollar valuation that has captured industry attention. The lofty figure is…